ATE552251T1 - Thiophen- und furanverbindungen - Google Patents
Thiophen- und furanverbindungenInfo
- Publication number
- ATE552251T1 ATE552251T1 AT05704861T AT05704861T ATE552251T1 AT E552251 T1 ATE552251 T1 AT E552251T1 AT 05704861 T AT05704861 T AT 05704861T AT 05704861 T AT05704861 T AT 05704861T AT E552251 T1 ATE552251 T1 AT E552251T1
- Authority
- AT
- Austria
- Prior art keywords
- thiophene
- furan compounds
- alzheimer
- schizophrenia
- relates
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04380005 | 2004-01-09 | ||
| US55208004P | 2004-03-10 | 2004-03-10 | |
| PCT/US2005/000004 WO2005070916A1 (en) | 2004-01-09 | 2005-01-05 | Thiophene and furan compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE552251T1 true ATE552251T1 (de) | 2012-04-15 |
Family
ID=45935348
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05704861T ATE552251T1 (de) | 2004-01-09 | 2005-01-05 | Thiophen- und furanverbindungen |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US7642361B2 (de) |
| EP (1) | EP1706395B1 (de) |
| AT (1) | ATE552251T1 (de) |
| ES (1) | ES2383115T3 (de) |
| WO (1) | WO2005070916A1 (de) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE602006003661D1 (de) | 2005-06-06 | 2008-12-24 | Lilly Co Eli | Ampa-rezeptoren-verstärker |
| TW200817385A (en) * | 2006-07-04 | 2008-04-16 | Organon Nv | Heterocyclic derivatives |
| JP2010143826A (ja) * | 2007-04-12 | 2010-07-01 | Mitsui Chemicals Inc | ３−アミノチオフェン誘導体の製造方法 |
| TW200934497A (en) | 2007-11-13 | 2009-08-16 | Organon Nv | Heterocyclic derivatives |
| WO2009067597A1 (en) * | 2007-11-21 | 2009-05-28 | Decode Genetics Ehf | 4- (or 5-) substituted catechol derivatives |
| TW201012803A (en) | 2008-06-06 | 2010-04-01 | Organon Nv | Heterocyclic derivatives |
| US20100016609A1 (en) * | 2008-07-15 | 2010-01-21 | Wyeth | Methods for the preparation of azole compounds |
| US8680139B2 (en) | 2009-04-01 | 2014-03-25 | Progenra | Anti-neoplastic compounds, compositions and methods |
| CA2758105A1 (en) | 2009-04-09 | 2010-10-14 | N.V. Organon | Indane derivatives |
| US9656959B2 (en) | 2010-12-22 | 2017-05-23 | Purdue Pharma L.P. | Substituted pyridines as sodium channel blockers |
| CN110818660B (zh) * | 2012-09-21 | 2023-09-12 | 罗得岛医院 | 用于治疗癌症的β-羟化酶抑制剂 |
| WO2014078568A1 (en) | 2012-11-14 | 2014-05-22 | The Johns Hopkins University | Methods and compositions for treating schizophrenia |
| KR20150130491A (ko) | 2013-03-13 | 2015-11-23 | 제넨테크, 인크. | 피라졸로 화합물 및 그것의 용도 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0273602A1 (de) | 1986-12-05 | 1988-07-06 | Eli Lilly And Company | 3-Cyano-4-arylthiophene |
| PE20000942A1 (es) * | 1998-07-31 | 2000-09-28 | Lilly Co Eli | Derivados de amida, carbamato y urea |
| EP1237849A1 (de) * | 1999-11-05 | 2002-09-11 | University College London | Aktivatoren der löslichen guanylatcyclase |
| US6835745B2 (en) * | 2002-01-15 | 2004-12-28 | Wyeth | Phenyl substituted thiophenes as estrogenic agents |
| US20030181468A1 (en) * | 2002-03-21 | 2003-09-25 | Michaelides Michael R. | Thiopyrimidine and isothiazolopyrimidine kinase inhibitors |
-
2005
- 2005-01-05 AT AT05704861T patent/ATE552251T1/de active
- 2005-01-05 WO PCT/US2005/000004 patent/WO2005070916A1/en active Application Filing
- 2005-01-05 US US10/596,419 patent/US7642361B2/en not_active Expired - Fee Related
- 2005-01-05 ES ES05704861T patent/ES2383115T3/es active Active
- 2005-01-05 EP EP05704861A patent/EP1706395B1/de not_active Not-in-force
Also Published As
| Publication number | Publication date |
|---|---|
| ES2383115T3 (es) | 2012-06-18 |
| WO2005070916A1 (en) | 2005-08-04 |
| US7642361B2 (en) | 2010-01-05 |
| EP1706395B1 (de) | 2012-04-04 |
| EP1706395A1 (de) | 2006-10-04 |
| US20070105852A1 (en) | 2007-05-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ595571A (en) | Pyrazole compounds and uses thereof | |
| GB0421639D0 (en) | Methods and compositions relating to alzheimer's disease | |
| NO20054640D0 (no) | Fremgangsmater for behandling av Parkinsons sykdom | |
| TW200736255A (en) | 5-(Substituted)-pyrazolopiperidines | |
| WO2007058602A3 (en) | Novel 2-amino-imidazole-4-one compounds and their use in the manufacture of a medicament to be used in the treatment of cognitive impairment, alzheimer’s disease, neurodegeneration and dementia. | |
| ATE535236T1 (de) | Therapeutische strategien für die prävention und behandlung der alzheimer-krankheit | |
| DK1594833T3 (da) | 1-phenylalkancarboxylsyrederivater til behandling af neurodegenerative sygdomme | |
| BR0314059A (pt) | Compostos heterocìclicos | |
| PL1765388T3 (pl) | Terapia skojarzona do zapobiegania chorobie Alzheimera lub leczenia tej choroby oraz zestaw do tego celu | |
| ATE552251T1 (de) | Thiophen- und furanverbindungen | |
| ATE486597T1 (de) | 3,4-substituierte pyrrolidin-derivate zur behandlung von hypertonie | |
| ATE534391T1 (de) | 3,11b-cis-dihydrotetrabenazin zur behandlung von psychosen | |
| EA200800880A1 (ru) | Комбинация росиглитазона и донепезила, предназначенная для улучшения когнитивной функции | |
| IL177787A0 (en) | 1-aminovyclohexane derivatives for the treatment of agitation and other behavioral disorders, especially those associated with alzheimer's disease | |
| HK1080467A1 (en) | Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders | |
| ATE449776T1 (de) | Pyrroloä2,3-cüpyridinderivate | |
| EA200801302A1 (ru) | Композиции и способы лечения нарушений цнс | |
| DE602006014305D1 (de) | Pyrroloä2,3-büpyridinderivate als modulatoren des h3-rezeptors | |
| TW200716152A (en) | Substituted 1,2-ethylendiamines, medicaments comprising said compound, their use and their method of manufacture | |
| EA200702004A1 (ru) | Соль безилата 7-(2-(4-(3-трифторметилфенил)-1,2,3,6-тетрагидропирид-1-ил)этил)изохинолина, ее получение и применение в терапии | |
| WO2007017511A3 (de) | Verbindungen zur behandlung der alzheimer erkrankung | |
| DE60233350D1 (de) | IMIDAZOi2,1-B -1,3,4-THIADIAZOLE SULFONAMIDES | |
| DE602005002776D1 (de) | Verfahren zur Herstellung von 1,3-Dihydro-2H-3-Benzazepin-2-on und Anwendung zur Herstellung von Ivabradine und ihren pharmazeutischen annehmbaren Salzen | |
| CR11447A (es) | Moduladores de piperidinil y piperazinil de y secretasa | |
| EA201070494A1 (ru) | МОДУЛЯТОРЫ γ-СЕКРЕТАЗЫ С АМИДНЫМИ СВЯЗЯМИ |